Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington’s disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics

BACKGROUND: Huntington’s disease (HD) is a hereditary, neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms. Currently, HD can only be managed symptomatically, including a large variety of prescribed drugs. Many HD patients experience negative medication effects (e....

Descripción completa

Detalles Bibliográficos
Autores principales: Feleus, Stephanie, van der Lee, Maaike, Swen, Jesse J., Roos, Raymund A. C., de Bot, Susanne T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634258/
https://www.ncbi.nlm.nih.gov/pubmed/37955016
http://dx.doi.org/10.1177/26330040231204643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634258/
https://www.ncbi.nlm.nih.gov/pubmed/37955016
http://dx.doi.org/10.1177/26330040231204643

Ejemplares similares